Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnsilica Regulatory News (ENSI)

Share Price Information for Ensilica (ENSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 55.00
Ask: 57.00
Change: 0.20 (0.36%)
Spread: 2.00 (3.636%)
Open: 56.50
High: 56.50
Low: 56.00
Prev. Close: 55.80
ENSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Results

26 Feb 2024 07:00

RNS Number : 3553E
EnSilica PLC
26 February 2024
 

Prior to publication, the information contained within this announcement was deemed by the Group to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain. 

 

26 February 2024 

 

EnSilica plc 

("EnSilica", the "Company" or the "Group") 

 

Unaudited Results for the Half Year Ended 30 November 2023 

 

Strong new order momentum supports growing order book and new business pipeline.  

 

EnSilica (AIM: ENSI), a leading chip maker of mixed-signal ASICs (Application Specific Integrated Circuits), is pleased to announce its unaudited results for the six months ended 30 November 2023 ("H1 FY24" or the "Period"). 

 

Financial Highlights 

 

· Revenue up 11.5% to £9.6 million (H1 FY23: £8.6 million) 

· Adjusted operating profit £0.06 million (H1 FY23: £0.15 million) 

· Gross margin up to 43.9% (H1 FY23: 42.5%) 

· Adjusted EBITDA £0.51 million (H1 FY23: £0.66 million) 

· Cash and cash equivalents at 30 November 2023 of £2.1 million (31 May 2023: £3.1 million) 

· Debt reduced by 10.3% to £3.7 million at 30 November 2023 (31 May 2023: £4.2 million) 

· New supply contract work resulted in further investment in IP of £3.02 million (H1 FY23: £1.7 million) 

 

Operational Highlights 

 

· Ongoing contract momentum across the Period, including: 

Secured production tape-out milestone for the design & supply of an industrial ASIC with production revenues estimated to be worth in excess of US$30 million over seven years;

Awarded sensor ASIC supply contract for the e-mobility market worth in excess of US$7 million; 

Secured a follow-on contract with an existing Europe-based customer for c.US$2.4 million; and 

New lead customer contract secured for EnSilica's proprietary satellite broadband chip worth ?2.5 million. 

· Continued investment in R&D initiatives alongside further development of the Group's sales and marketing activities.

 

Post Period-end Events 

 

· Solid start to the second half of the year, with committed supply revenues of c.US$73 million and a strong pipeline of opportunities currently valued at c.US$512 million, underpinning FY24 market expectations. 

· Released Post-Quantum Cryptography Accelerators Intellectual Property ("IP"), securing first customer licence with a major semiconductor supplier. 

· Awarded initial mandate for a high-end telecoms ASIC, with final contract worth in excess of US$35 million. 

· Equity raise of £1.56 million in December 2023 to support new business opportunities. 

· Appointed Kristoff Rademan as Chief Financial Officer with Kristoff set to join in May 2024.

· Advanced discussions for a £1.0 million debt facility and invoice finance facilities as cashflows reliant on short-term receipt of significant customer payments and R&D tax credits.

 

 

Ian Lankshear, Chief Executive Officer of EnSilica, commented

 

"We are delighted with the continued operational progress delivered across the Period, particularly the quantity and quality of contract wins secured with companies across a range of sectors. This is testament to our expert team which is highly focused on driving the growth of the business and helping EnSilica deliver on its strategic ambitions. 

 

Pleasingly, this significant new business momentum has continued into the second half of the financial year. EnSilica has already signed a multi-million-pound initial mandate with an established telecoms equipment supplier, whilst we recently achieved a new milestone by securing our first customer licence with a leading semiconductor supplier through release of our Post-Quantum Cryptography accelerators IP. 

 

Looking ahead, we will seek to further enhance our intellectual property portfolio and drive our sales and marketing capabilities to ensure we remain at the forefront of the market and are best positioned to strengthen our reputation as a leading and innovation-led chip maker." 

 

 

For further information please contact: 

 

EnSilica plc 

Ian Lankshear, Chief Executive Officer

www.ensilica.com 

 

Via Vigo Consulting 

+44 (0)20 7390 0233 

Allenby Capital Limited, Nominated Adviser & Broker 

Jeremy Porter / Vivek Bhardwaj (Corporate Finance) 

Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking) 

 

Tel: +44 (0)20 3328 5656 

info@allenbycapital.com 

 

Vigo Consulting (Investor & Financial Public Relations) 

Jeremy Garcia / Kendall Hill 

ensilica@vigoconsulting.com

+44 (0)20 7390 0233 

 

About EnSilica plc  

 

EnSilica is a leading fabless design house focused on custom ASIC design and supply for OEMs and system houses, as well as IC design services for companies with their own design teams. The company has world-class expertise in supplying custom RF, mmWave, mixed signal and digital ICs to its international customers in the automotive, industrial, healthcare and communications markets. The company also offers a broad portfolio of core IP covering cryptography, radar, and communications systems. EnSilica has a track record in delivering high quality solutions to demanding industry standards. The company is headquartered near Oxford, UK and has design centres across the UK and in Bangalore, India and Porto Alegre, Brazil.

 

Operational Review 

 

We are pleased to report continued operational momentum across H1 FY24, with customer demand for our services remaining strong. 

 

During the Period, the Group generated £9.6 million in revenues (H1 FY23: £8.6 million), an increase of 11.5% on H1 FY23, and £0.51 million in EBITDA versus £0.66 million in H1 FY23. The reduction in EBITDA, against a backdrop of growing our revenue base, highlights the ongoing investment we continue to make across the business. 

 

Cash and cash equivalents at 30 November 2023 was £2.1 million (31 May 2023: £3.1 million) and the Group reduced debt during the Period by 10.3% to £3.7 million at 30 November 2023 (31 May 2023: £4.2 million).

 

The global ASIC chips market was valued at US$1.67 billion in 2023 and is expected to reach US$25.08 billion by the end of 2030, delivering a CAGR of 5.1% between 2024-20301. The telecommunications, automobiles, industrial and aerospace sectors, all key growth markets that EnSilica focuses on, continue to be heavy consumers of ASICs given their ability to support data encryption, signal processing and sensor interfacing, all of which are typically developed for a specific application. 

 

EnSilica continues to benefit from these market trends, supported by our niche specialisms and underpinned by our strategic priorities, namely: 

 

· Leverage EnSilica's strong position and relevant intellectual property rights within automotive, industrial, healthcare, and satellite connectivity applications for mixed signal ASICs; 

· Scale the Company's successful fabless ASIC model to fully exploit revenue opportunities from design and supply engagements; 

· Develop Application Specific Standard Products ("ASSPs") to address key customer driven opportunities, with two significant standard platforms already at the device evaluation stage; and 

· Expand EnSilica's offering through consolidation and vertical integration. 

 

The Group delivered ongoing contract momentum in H1 FY24, including a production tape-out milestone of an industrial ASIC with production revenues estimated to be worth in excess of US$30 million over the next seven years. The ASIC is for a leading European industrial OEM and is a key component in their factory automation controller systems. 

 

In addition, the team has secured a number of important contracts with both new and existing customers, including mandates with companies operating in burgeoning markets such as satellite communications and e-mobility. 

 

Recruitment is a key focus of the Company as it continues to explore new commercial opportunities to grow its customer portfolio. In the Period, EnSilica added a total of 8 employees to its already strong R&D, sales and marketing departments, and the Company expects these highly experienced new hires to help facilitate its global footprint expansion, especially in jurisdictions where EnSilica is actively seeking to expand its market presence. 

 

The Company has seen a particular increase in interest for its services in the US, leading to the establishment of the EnSilica USA Inc. subsidiary, which has already built a strong relationship with relevant critical suppliers and a highly promising pipeline of additional business opportunities. The Company has also negotiated and secured improved relationships with key suppliers in Europe, further consolidating EnSilica's position as a go-to ASIC partner. 

 

Management believes that custom chips will continue to play an important role in the further development of the Group's key growth sectors, which collectively now support a new business pipeline of c.US$512 million. 1 https://www.verifiedmarketreports.com/product/asic-chips-market-size-and-forecast/ 

 

Post Period End & Outlook 

 

The Company has made a strong start to H2 FY24, announcing an initial mandate for a high-end telecoms ASIC, ahead of a final contract being entered into for the full design and supply of the ASIC for a total contract value estimated to be worth in excess of US$35 million. The initial work is being funded by non-recurring engineering fees, fully funded by the customer, with initial ASIC production and supply anticipated to begin at the end of the calendar year 2026, subject to final contract. 

 

EnSilica also released a range of Post-Quantum Cryptography accelerators, with the first of these IP licences granted to a major semiconductor supplier in January 2024. This award further validates the intrinsic value of the Group's IP, as EnSilica not only licences its IP to other semiconductor companies, but also leverages it in the development of custom ASICs which the Company supplies to its clients. 

 

The current sales pipeline of opportunities and potential contracts stands at c.US$512 million following a review by management to focus on projects which meet our criteria, and this pipeline remains a strong endorsement of the quality of our business output and our growing reputation in the chip sector.

 

EnSilica has delivered another robust first-half performance to continue its well-paced development, with the Group positioned to capitalise on growth opportunities in key geographies including the US. The Company is continuing to realise the positive impact of its prudent growth strategy targeting customer acquisitions across high-growth and tech-driven markets. 

 

Encouraged by the improving broader trading environment, management is looking ahead to the remainder of H2 FY24 and beyond with confidence and is excited to explore potential new mandate opportunities to add to the sizeable contract wins already secured in the second half of the financial year. 

  

Cashflow and new debt funding

 

Despite the excellent commercial progress being made, the Group's short term cashflow is currently dependent on the receipt of R&D tax credits (some of which was expected in December) and material customer payments, one of which is overdue and others are expected in March and April. This has led the Board to seek additional funding should these payments not materialise as expected and contracted. This includes the negotiation of invoice financing facilities and discussions with a lender for potential bridge funding of up to £1.0 million, the terms of which are expected to be agreed shortly. The Board remains confident on receipt of adequate funds such that these financial statements have been prepared on the basis that the Group remains a going concern, however, there is uncertainty relating to the timely receipt of customer payments and tax credits in the short term.

 

The Board continues to see great opportunity for EnSilica to continue to capitalise on the significant growth potential that exists within the international semiconductor industry and remains highly confident in the Group's future growth prospects. 

 

Mark Hodgkins Ian Lankshear 

Chair Chief Executive Officer

EnSilica plc EnSilica plc 

 

25 February 2024

 

Interim Financial Statements

 

Condensed Interim Consolidated Statement of Comprehensive Income

Condensed Interim Consolidated Statement of Financial Position

Condensed Interim Consolidated Statement of Changes in Equity

Condensed Consolidated Statement of Cash Flows

Notes to the Interim Condensed Consolidated Financial Statements

 

Interim Financial Statements

Condensed Interim Consolidated Statement of Comprehensive Income

for the six months ended 30 November 2023

 

 

 

 

 

Six months ended

30 Nov 2023

Six months ended

30 Nov 2022

Twelve months ended

31 May 2023

 

 

Unaudited

Unaudited

Audited

Note

 

£'000

£'000

£'000

Revenue

2

9,553

8,592

20,476

Cost of sales

(5,358)

(4,937)

(12,306)

Gross profit

4,195

3,655

8,170

Other operating income

-

8

8

Administrative expenses

(4,137)

(3,514)

(7,352)

 

Operating profit

 

 

 

58

 

149

 

825

Interest income

1

6

7

Interest expense

(368)

(357)

(785)

 

(Loss)/profit before taxation

 

(309)

(202)

47

Taxation

4

824

524

1,745

Profit for the period

515

322

1,792

 

Other comprehensive (expense)/ income for the period

Currency translation differences

(78)

5

(50)

Total comprehensive income for the period

437

327

1,742

 

Profit for the period attributable to:

Owners of the company

515

322

1,792

Non-controlling interests

-

-

-

515

322

1,792

 

Other comprehensive (expense)/ income for the period attributable to:

Owners of the company

(78)

5

(50)

Non-controlling interests

-

-

-

(78)

5

(50)

Total comprehensive income for the period attributable to:

Owners of the company

437

327

1,742

Non-controlling interests

-

-

-

437

327

1,742

 

 

Interim Financial Statements

Earnings per Share Attributable to the Owners of the Parent During the Period (expressed in pence per share)

 

Six months ended

30 Nov 2023

Six months ended

30 Nov 2022

Twelve months ended

31 May 2023

 

Unaudited

Unaudited

Audited

Note

pence

pence

pence

 

Basic earnings per share (pence)

5

0.66

0.43

2.36

Diluted earnings per share (pence)

5

0.64

0.39

2.30

 

Adjusted Basic earnings per share (pence)

5

0.66

0.43

2.47

Adjusted Diluted earnings per share (pence)

5

0.64

0.39

2.41

 

Interim Financial Statements

Condensed Interim Consolidated Statement of Financial Position

as at 30 November 2023

 

 

 

 

 

30 Nov 2023

Unaudited

30 Nov 2022

Unaudited

31 May 2023

Audited

Note

 

£'000

£'000

£'000

Assets

Non-current assets

Property, plant and equipment

6

3,049

2,711

2,566

Intangible assets

7

15,233

10,001

12,433

Total non-current assets

 

18,282

12,712

14,999

 

Current assets

Inventories

375

1,172

304

Trade and other receivables

8

5,886

5,344

7,025

Corporation tax recoverable

1,464

2,271

2,064

Cash and cash equivalents

2,092

1,359

3,095

Total current assets

9,817

10,146

12,488

 

Total assets

28,099

22,858

27,487

 

Current liabilities

Borrowings

9

(975)

(833)

(883)

Lease liabilities

(177)

(147)

(171)

Trade and other payables

10

(5,289)

(3,186)

(4,723)

Total current liabilities

(6,441)

(4,166)

(5,777)

 

Non current liabilities

Borrowings

9

(2,764)

(3,726)

(3,284)

Lease liabilities

(2,025)

(2,182)

(2,104)

Provisions

(194)

(206)

(199)

Deferred tax

(160)

-

(160)

Total non current liabilities

(5,143)

(6,114)

(5,747)

 

Total liabilities

(11,584)

(10,280)

(11,524)

 

Net assets

16,515

12,578

15,963

 

Equity

Issued share capital

11

137

134

137

Share premium account

8,752

6,900

8,752

Currency differences reserve

(126)

6

(49)

Retained earnings

7,752

5,538

7,123

Equity attributable to owners of the Company

16,515

12,578

15,963

Non-controlling interests

-

-

-

Total equity

16,515

12,578

15,963

 

The notes are an integral part of these condensed interim financial statements.

Ian Lankshear Mark Hodgkins

Chief Executive Officer Executive Chair

Company registration number: 04220106

 

 

Interim Financial Statements

Condensed Interim Consolidated Statement of Changes in Equity

 

Share capital

Share premium account

Currency translation reserve

Retained earnings

Attributable to owners of the parent

Non-controlling interests

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

At 31 May 2022

 

134

 

6,900

1

 

5,118

 

12,153

 

-

 

12,153

 

Comprehensive income for the six months to 30 November 2022

 

Profit for the period

-

 

-

-

322

322

-

322

Other comprehensive income

-

-

5

-

5

-

5

Total comprehensive income for the period

-

-

5

322

327

-

327

Share based payment

-

-

-

98

98

-

98

At 30 November 2022

 

134

 

6,900

6

 

5,538

 

12,578

 

-

 

12,578

 

 

 

Comprehensive expense for the six months to 31 May 2023

 

 

 

Profit for the period

-

-

-

1,471

1,471

-

1,471

Other comprehensive (expense)/income

-

-

(55)

-

(55)

-

(55)

Total comprehensive expense for the period

-

-

(55)

1,471

1,416

-

1,416

Share based payment

-

 

-

-

114

114

-

114

 

Issue of share capital

3

2,015

-

-

2,018

-

2,018

Costs of share issue

-

(163)

-

-

(163)

-

(163)

At 31 May 2023

 

137

 

8,752

(49)

 

7,123

 

15,963

 

-

 

15,963

 

 

Comprehensive income for the

six months to 30 November 2023 

Profit for the period

-

 -

-

515

515

-

515

Other comprehensive expense

-

 -

(78)

-

(78)

-

(78)

Total comprehensive (expense)/income for the period

-

-

(78)

515

437

-

437

Share based payment

-

 -

-

114

114

-

114

At 30 November 2023

137

8,752

(126)

7,752

16,515

16,515 

Interim Financial Statements

Interim Condensed Consolidated Statement of Cash Flows

for the six months ended 30 November 2023

 

 

 

 

 

 

 

 

 

Note

 

Six months

ended

30 Nov 2023

Unaudited

Six months ended

30 Nov 2022 

 Unaudited

Twelve months ended

31 May 2023 

Audited

 

 

£'000

£'000

£'000

Cash flows from operating activities

Cash generated/(used) from operations

A

2,249

(1,415)

290

Tax received/(paid)

1,424

(76)

1,512

Net cash generated from/(used in) operating activities

3,672

(1,491)

1,802

 

Cash flows from investing activities

Purchase of property, plant and equipment

(711)

(336)

(395)

Additions to intangible assets

(3,018)

(1,731)

(4,133)

Interest received

1

6

7

Net cash used in investing activities

(3,728)

(2,061)

(4,521)

 

Cash flows from financing activities

Proceeds from issuance of ordinary shares

-

-

1,855

Interest paid

(369)

(357)

(785)

Lease liability payments

(73)

(60)

(166)

Repayment of bank loans

(428)

(413)

(832)

Net cash (used in)/ generated from financing activities

(870)

(830)

72

 

Net decrease in cash and cash equivalents

(926)

(4,383)

(2,647)

Cash and cash equivalents at beginning of year

3,095

5,742

5,742

Foreign exchange losses

(78)

-

-

Cash and cash equivalents at end of period

B

2,092

1,359

3,095

 

Interim Financial Statements

Notes to the Condensed Interim Consolidated Statement of Cash Flows

for the six months ended 30 November 2023

 

A. Cash generated from operations

The reconciliation of profit for the year to cash generated from operations is set out below:

 

 

 

 

 

 

 

Six months

ended

30 Nov 2023

Six months ended

30 Nov 2022

Twelve months ended

31 May 2023

 

 

£'000

£'000

£'000

Profit for the period

 

515

322

1,792

Adjustments for:

Depreciation

227

199

454

Amortisation of intangible assets

218

307

248

Other amortisation

12

7

28

Share based payments

114

98

213

Net interest costs

368

351

778

Tax credit

(824)

(524)

(1,745)

 

 

630

760

1,768

Working capital movements

 

 

 

Increase in inventories

(73)

(957)

(89)

Decrease/(increase) in trade and other receivables 

1,139

(2,088)

(3,770)

Increase in trade and other payables

558

804

2,322

(Decrease)/increase in provisions

(5)

66

59

Cash generated from / (used in) operations

 

2,249

(1,415)

290

 

B. Analysis of net debt

 

At

1 June 2022

Cash flow

Non-cash changes

At

30 Nov 2022

 

£'000

£'000

£'000

£'000

Loans

(4,966)

413

-

(4,553)

Lease liabilities

(193)

49

10

(134)

Liabilities arising from financing activities

(5,159)

462

10

(4,687)

Cash and cash equivalents

5,742

(4,383)

-

1,359

Net debt

583

(3,921)

10

(3,328)

 

 

 

 

 

 

At

1 Dec 2022

Cash flow

Non-cash changes

At

31 May 2023

 

£'000

£'000

£'000

£'000

Loans

(4,553)

419

(33)

(4,167)

Lease liabilities

(134)

314

(2,455)

(2,275)

Liabilities arising from financing activities

(4,687)

733

(2,488)

 (6,442)

Cash and cash equivalents

1,359

1,736

-

3,095

Net debt

(3,328)

2,469

(2,488)

(3,347)

 

 

 

At

1 June 2023

Cash flow

Non-cash changes

At

30 Nov 2023

 

£'000

£'000

£'000

£'000

Loans

(4,167)

428

-

(3,739)

Lease liabilities

(2,275)

73

-

(2,202)

Liabilities arising from financing activities

 (6,442)

501

-

(5,941)

Cash and cash equivalents

3,095

(926)

(77)

2,092

Net debt

(3,347)

(425)

(77)

(3,849)

 

 

Interim Financial Statements

Notes to the Condensed Interim Consolidated Financial Statements

For the Period ended 30 November 2023

 

1. General information   Ensilica plc is a public limited company incorporated in the United Kingdom, quoted on the AIM Market of the London Stock Exchange. The Company is domiciled in the United Kingdom and its registered office is 100 Park Drive, Milton Park, Abingdon, OX14 4RY.

The condensed consolidated interim financial statements were approved for issue on 25 February 2024.

The condensed consolidated interim financial statements have not been audited or reviewed.

The condensed consolidated interim financial statements do not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 May 2023 were approved by the Board of Directors on 9 October 2023 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under section 498 of the Companies Act 2006.

The condensed consolidated interim financial statements comprise the Company and its subsidiaries (together referred to as the 'Group').

Basis of preparation

This condensed consolidated interim financial report for the period ended 30 November 2023 has been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.

The interim report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the Annual Report and Consolidated Financial Statements for the year ended 31 May 2023 and any public announcements made by EnSilica plc during the interim reporting period.

The consolidated financial statements of the Group have been prepared in accordance with UK-adopted International Accounting Reporting Standards (IAS) as issued by the International Accounting Standards Board (IASB) and the Companies Act 2006.

The financial information has been prepared under the historical cost convention unless otherwise specified within these accounting policies. The financial information and the notes to the financial information are presented in thousands of pounds sterling ('£'000'), the functional and presentation currency of the Group, except where otherwise indicated.

The principal accounting policies adopted in preparation of the financial information are set out below. The policies have been consistently applied to all periods presented, unless otherwise stated.

Judgements made by the Directors in the application of the accounting policies that have a significant effect on the financial information and estimates with significant risk of material adjustment in the next year are discussed below.

 

Going concern

In assessing the appropriateness of the going concern assumption, the Board has considered the availability of funding alongside the possible cash requirements of the Group and Company. After due consideration and in the expectation of receipt of tax credits and customer payments in the short term as set out below, the directors have concluded that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for at least 12 months from the date of this report, but in reaching that conclusion the Board is mindful of the following key sensitivities which, should they materialise, could cast significant doubt on that conclusion.

 

The Board originally anticipated to receive R&D tax credit from HMRC in December 2023. While the timing of the receipt of this continues to remain outside of the Company's control, this is now anticipated to be received in the first quarter of 2024. The Company also expects to receive certain significant customer payments, including in relation to two separate contracts, one of which was announced on 14 December 2023 and is expected in March 2024, for work completed and which is overdue. In view of this, the Board has prepared various sensitivity analyses to determine circumstances in which the Company might need additional funding in order to meet short-term working capital requirements. It has determined that there remains an uncertainty as to the adequacy of funding in the following circumstances:

1. the Company does not enter into any interim bridging financing arrangement; and/or

2. the Company does not receive the payments outlined above in relation to customer contracts.

 

Accordingly, as a matter of prudence, the Board is negotiating invoice financing and is in discussions for £1.0 million in debt finance to increase financial headroom and resilience.

Accounting policies

The accounting policies adopted are consistent with those of the previous financial year.

 

Use of estimates and assumptions

The preparation of interim financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

In preparing these condensed interim financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the annual financial statements for the year ended 31 May 2023.

Financial instruments

The Group's financial instruments comprise cash and cash equivalents, receivables and payables arising directly from operations, and derivatives. The directors consider that the fair values of the Group's financial instruments do not differ significantly from their carrying values.

 

2. Analysis of revenue

The Board continues to define all the Group's trading as operating in the integrated circuit design market and considers all revenue to relate to the same, one operating segment. Revenue is defined as per the accounting policies.

Revenue in respect of the supply of products is recognised at a point in time. Design and related services, including income for the use of IP, are recognised over the period when services are provided.

 

 

Six months

ended

30 Nov 2023

Six months

ended

30 Nov 2022

Twelve months ended

31 May 2023

 

£'000

£'000

£'000

Recognised at a point in time

Supply of products

 

1,071

 

1,235

 

2,856

Recognised over time

NRE design services

3,820

3,409

8,175

Consultancy design services

4,640

3,700

9,400

Licensing related income

22

248

45

8,482

7,357

17,620

9,553

8,592

20,476

By destination:

UK

1,413

970

1,831

Rest of Europe

4,639

4,432

11,817

Rest of the World

3,502

3,190

6,828

Total revenue

9,553

8,592

20,476

 

The nature of the design services and projects is such that there will be significant customers as a proportion of revenue in any one reporting period but that these may be different customers and volumes from one period to the next. During the six months to 30 November 2023 there were five customers with sales between £1.0m and £2.0m contributing 73% of total revenue whereas in the comparable period to 30 November 2022 two customers had sales amounting to £2.6m and £2.0m respectively contributing 53% of revenues with remaining sales being less than £1.0m to each customer.

 

The group's non-current assets comprising investments, tangible and intangible fixed assets, and the net assets by geographical location are:

 

30 Nov 2023

 

30 Nov 2022

 

31 May 2023

 

 

 

Non-current assets

Net assets

Non-current assets

Net assets

Non-current assets

Net assets

 

 

£'000

£'000

£'000

£'000

£'000

£'000

 

United Kingdom

18,183

15,393

12,570

11,244

14,892

14,967

India

34

1,429

62

1,251

34

1,199

Brazil

65

120

80

84

73

67

Germany

(427)

-

(270)

18,282

16,515

12,712

12,578

14,999

15,963

 

3. Alternative performance measures

These items are included in normal operating costs of the business but are significant cash and non-cash expenses that are separately disclosed because of their size, nature or incidence. It is the Group's view that excluding them from operating profit gives a better representation of the underlying performance of the business in the year.

The Group's primary results measure, which is considered by the directors of Ensilica plc to better represent the underlying and continuing performance of the Group, is Adjusted EBITDA as set out below. EBITDA is a commonly used measure in which earnings are stated before net finance income, amortisation and depreciation as a proxy for cash generated from trading.

 

 

Six months ended

30 Nov 2023

Six months

ended

30 Nov 2022

Twelve months ended

31 May 2023

 

 

£'000

£'000

£'000

Operating profit before interest

58

149

825

Compensation for loss of office

-

-

85

Adjusted Operating profit before interest

58

149

910

Depreciation

227

199

454

Amortisation

230

314

276

Adjusted EBITDA

 

515

662

1,640

 

 

 

 

 

Profit for the period

515

322

1,792

Compensation for loss of office

-

-

85

Adjusted Profit for the period

 

515

322

1,877

 

 

 

4. Taxation on profit

 

Six months

ended

30 Nov 2023

Six months

ended

30 Nov 2022

Twelve months

ended

31 May 2023

 

 

£'000

£'000

£'000

 

Current taxation

 

UK corporation tax credit

900

600

2,064

 

Foreign tax charge

(76)

(76)

(159)

 

 

824

524

1,905

 

Deferred taxation

 

Origination and reversal of timing differences

-

-

(160)

Tax credit on profit/(loss)

824

524

1,745

 

 

Factors affecting the tax credit for the period

The tax credit on the profit/(loss) for the year differs from applying the standard rate of corporation tax in the UK of 25% (2023: 20%). The differences are reconciled below:

 

Six months

ended

30 Nov 2023

Six months

ended

30 Nov 2022

Twelve months ended

31 May 2023

 

£'000

£'000

£'000

(Loss)/profit before taxation

(309)

(202)

47

 

Corporation tax at standard rate

(77)

(38)

9

Factors affecting charge for the year:

Disallowable expenses

103

127

164

Allowances and enhanced deductions

(772)

-

(966)

Research and development allowances

(726)

(807)

(1,940)

Reduced rate on surrender of R&D losses for tax credit

683

115

762

RDEC expenditure credit

(79)

-

(62)

Restricted tax losses

-

79

-

Foreign tax charges

15

-

85

Deferred tax

-

-

160

Share options

29

-

43

Tax credit on (loss)/profit

(824)

(524)

(1,745)

 

5. Earnings per share

 

 

Six months ended 30 Nov 2023

Six months ended 30 Nov 2022

Twelve months ended

31 May 2023

Profit used in calculating EPS (£'000)

 

515

322

1,792

Number of shares for basic EPS ('000s)

78,115

75,232

75,833

Basic earnings per share (pence)

 

0.66

0.43

2.36

Number of shares for diluted EPS ('000s)

80,134

82,767

77,874

Diluted earnings per share (pence)

 

0.64

0.39

2.30

 

Adjusted Earnings per share

 

Six months ended

30 Nov 2023

Six months ended

30 Nov 2022

Twelve months ended

31 May 2023

Adjusted Profit used in calculating EPS (£'000)

515

322

1,877

Number of shares for basic EPS ('000s)

78,115

75,232

75,833

Adjusted basic earnings per share (pence)

0.66

0.43

2.47

Number of shares for diluted EPS ('000s)

80,134

82,767

77,874

Adjusted diluted earnings per share (pence)

0.64

0.39

2.41

 

There are 424,440 of exercisable share options over ordinary shares respectively which are potentially dilutive to profit.

 

As part of the Company's 2022 long term incentive plan, share options over 6,751,109 ordinary shares and warrants over 450,000 ordinary shares are potentially dilutive to profit.

 

 

6. Property, plant and equipment

 

 

Right-of-use property

Leasehold improvements

Office equipment

Right-of-use equipment

Computer equipment

Total

£'000

£'000

£'000

£'000

£'000

£'000

Cost

 

 

 

 

At 1 June 2023

2038

240

240

597

563

3,678

Additions

-

-

2

640

69

711

At 30 November 2023

2,038

240

242

1,237

632

4,389

Depreciation

At 1 June 2023

(367)

(24)

(111)

(204)

(405)

(1,111)

Charge for the year

(91)

(6)

(22)

(53)

(54)

(227)

At 30 November 2023

(458)

(30)

(133)

(257)

(459)

(1,338)

Net book value

At 30 November 2023

1,580

210

109

980

169

 

3,049

At 31 May 2023

1,671

216

129

393

155

 

2,566

At 30 November 2022

1,791

226

147

390

157

 

2,711

 

7. Intangible assets

 

 

 

Development costs

Software

 

Intellectual

property 

Total

 

£'000

£'000

£'000

£'000

Cost

At 1 June 2023

15,478

123

39

15,640

Additions

3,018

-

-

3,018

At 30 November 2023

18,496

123

39

18,658

Amortisation and impairment

At 1 June 2023

(3,152)

(51)

(4)

(3,207)

Charge for the period

(205)

(11)

(2)

(218)

At 30 November 2023

(3,357)

(62)

(6)

(3,425)

Net book value

At 30 November 2023

 

15,139

61

33

15,233

At 31 May 2023

 

12,326

72

35

12,433

At 30 November 2022

 

9,877

84

40

10,001

 

Capitalised development expenditure relates to developed intellectual property in respect of circuit and chip design.

 

The recoverable amount of a cash generating unit (CGU) is assessed using a value in use model across each individual project that forms the intellectual property that has been capitalised. The value in use for each project is dependent on the envisaged life cycle of the CGU using a discount factor of 11.5% (2022:10%), being the cost of capital for the CGU.

 

8. Trade and other receivables

 

 

30 Nov 2023

30 Nov 2022

31 May 2023

Current 

£'000

£'000

£'000

Trade receivables

1,364

1,661

3,893

Other receivables

1,093

952

807

Prepayments

703

562

483

Accrued income

2,726

2,169

1,842

Total

5,886

5,344

7,025

 

 

9. Borrowings

 

 

30 Nov 2023

30 Nov 2022

31 May 2023

Current

£'000

£'000

£'000

Bank loans

975

833

883

 

 

 

Non-current

Bank loans

2,764

3,726

3,284

 

Total

3,739

4,559

4,167

 

A bank loan of £1,440,000 (2022: £1,867,000) is secured by fixed and floating charges over the assets of the group and bears interest at rates of 8% over SONIA or 10% if higher. It is repayable in monthly instalments over the period to August 2026.

 

A loan of £1,939,000 (2022: £2,875,000) is unsecured and bears interest at a fixed rate of 13%. It is being repaid by quarterly instalments over the period to October 2027.

 

The loan liabilities are stated net of unamortised loan issue costs as at 30 November 2023 of £140,000 (2022: £189,000) which are being amortised over the period to the loan repayment dates.

 

 

10. Trade and other payables

 

 

30 Nov 2023

30 Nov 2022

31 May 2023

Current

£'000

£'000

£'000

Trade payables

2,051

1,475

2,388

Taxation and social security

542

519

281

Other payables

166

120

161

Accruals

2,249

939

1,293

Contract liabilities

281

133

600

Total

5,289

3,186

4,723

 

11. Share capital

 

 

 

 

Allotted, called up and fully paid

30 Nov 2023

30 Nov 2022

31 May 2023

£'000

£'000

£'000

78,115,158 ordinary shares of £0.001 each

78

75

78

59,190 deferred shares of £1.00 each

59

59

59

 

137

134

137

 

12. Share based payment

 

The company does not report share based payment detailed analysis as part of its half year reporting.

 

An estimated provision totalling £114,000 (30 November 2022 £98,000) has been made for the period under review.

 

 

13. Post balance sheet events

 

Subsequent to the end of the period under review there have been no events that the company feels should be brought to the shareholders' attention.

 

 

14. Related party transactions

 

During the period under review, the company undertook transactions with the following related parties:

 

Six months to 30 Nov 2023

 

Six months to 30 Nov 2022

 

Twelve months to 31 May 2023

Name

Services

Transactions during the period

Balance owing/ (owed) at 30 Nov 2023£'000

Transactions during the period

Balance owing/ (owed) at 30 Nov 2022£'000

Transactions during the year

Balance owing/ (owed) at 31 May 2023 £'000

 

 

 

 

 

 

 

Ensilica India Private Limited

Semiconductor design services

586

770

724

770

1,282

-

 

EnSilica Do Brasil Sociedade Unipessoal Limitada

Semiconductor design services

609

-

535

-

1,187

-

 

EnSilica GMBH

Semiconductor sales services

150

(150)

-

-

271

(271)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EAAASAESLEAA
12
Date   Source Headline
4th Apr 20247:00 amRNSExercise of Warrants, Issue of Equity & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
20th Mar 20249:08 amRNSAppointment of Joint Broker
18th Mar 202412:40 pmRNSResult of General Meeting & Total Voting Rights
18th Mar 20247:00 amRNSExercise of Warrants, Issue of Equity & TVR
4th Mar 20247:00 amRNSArm-Based Technology Contract Win
29th Feb 20247:00 amRNSReceipt of R&D tax credit
28th Feb 20247:00 amRNSSignificant c.US$20 million Supply Win
27th Feb 20242:24 pmRNSPlacing to raise £1.1 million and notice of GM
26th Feb 20247:00 amRNSHalf-year Results
19th Feb 20247:00 amRNSNotice of Results and Investor Presentation
14th Feb 202411:49 amRNSHolding(s) in Company
5th Feb 20247:00 amRNSAppointment of Chief Financial Officer
12th Jan 20247:00 amRNSPost Quantum Cryptography Accelerators IP Release
29th Dec 20231:00 pmRNSTotal Voting Rights
22nd Dec 20237:00 amRNSEnSilica awarded initial mandate for telecoms ASIC
21st Dec 202312:51 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSPlacing to Raise £1.56m & New Business Update
28th Nov 202312:27 pmRNSResult of AGM
28th Nov 20237:00 amRNSAGM Statement & Trading Update for the Half Year
10th Oct 20237:01 amRNSProduction tape-out milestone of industrial ASIC
10th Oct 20237:00 amRNSAudited Full Year Results
3rd Oct 20237:00 amRNSNotice of annual results & investor presentation
13th Sep 20237:00 amRNSUS$7m e-mobility sensor ASIC supply contract win
1st Sep 20237:00 amRNSEnSilica secures follow-on $2.4m contract
30th Aug 20237:00 amRNSEUR2.5m Satellite Broadband Chip Contract Secured
22nd May 20237:00 amRNSAdditional automotive ASIC supply mandate
27th Apr 20237:00 amRNSTrading Update
14th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:01 amRNSDirectorate Change
11th Apr 20237:00 amRNSASIC Contract Extension
3rd Apr 20237:00 amRNS$2.4m contract secured with existing customer
31st Mar 20236:00 pmRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
21st Mar 20232:05 pmRNSSecond Price Monitoring Extn
21st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSResult of Retail Offer
9th Mar 20237:01 amRNSRetail Offer to raise up to £0.5 million
9th Mar 20237:00 amRNSPlacing & Subscription Raises £2m & Retail Offer
17th Feb 202311:05 amRNSSecond Price Monitoring Extn
17th Feb 202311:00 amRNSPrice Monitoring Extension
17th Feb 20239:05 amRNSSecond Price Monitoring Extn
17th Feb 20239:00 amRNSPrice Monitoring Extension
17th Feb 20237:01 amRNSEUR 5m Satellite Broadband Chip Contract Win
17th Feb 20237:00 amRNSUnaudited Half Year Results
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSNew contracts with existing customers worth $3.6m
9th Dec 202212:07 pmRNSNamed Company of the Year at UK Chip Oscars
24th Nov 202211:44 amRNSResult of Annual General Meeting
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.